By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bio-Path Holdings, Inc. 

2626 South Loop
Suite 180
Houston  Texas  77054  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Bio-Path Holdings, Inc. (BPTH) Reports First Quarter 2017 Financial Results 5/11/2017 11:17:18 AM
Bio-Path Holdings, Inc. (BPTH) To Announce First Quarter 2017 Financial Results On May 11, 2017 5/4/2017 10:29:35 AM
Bio-Path Holdings, Inc. (BPTH) Announces Appointment Of Dr. William Hahne As Vice President Of Clinical Development 4/17/2017 10:20:52 AM
Bio-Path Holdings, Inc. (BPTH) Presents Clinical Data Evaluating BP1001 As A Treatment For Chronic Myelogenous Leukemia At The 58th Annual American Society of Hematology Annual Meeting 12/7/2016 11:30:49 AM
Bio-Path Holdings, Inc. (BPTH) To Announce Third Quarter 2016 Financial Results On November 10, 2016 11/7/2016 7:43:08 AM
Bio-Path Holdings, Inc. (BPTH) Announces Research Collaboration On Autoimmune Indication With The University of Texas Southwestern Medical Center 3/23/2016 9:44:59 AM
Bio-Path Holdings, Inc. (BPTH) Reports Fiscal Year 2015 Operational And Financial Results 3/16/2016 10:43:43 AM
Bio-Path Holdings, Inc. (BPTH) Announces Pancreatic Cancer Research Collaboration With Leading Oncology Institution 3/8/2016 10:29:55 AM
Bio-Path Holdings, Inc. (BPTH) To Present At The 28th Annual ROTH Conference 3/7/2016 9:44:57 AM
Bio-Path Holdings, Inc. (BPTH) Announces Completion Of The Safety Segment Of The Phase II Clinical Trial Of BP1001 In Acute Myeloid Leukemia 3/3/2016 10:34:08 AM
123456789
//-->